跳至主要内容
临床试验/PACTR202103785412583
PACTR202103785412583已完成未知

Intravenous lidocaine infusion with single low-dose ketamine as an adjuvant to general anesthesia in posterior spine fusion

Mostafa Mansour Hussein0 个研究点目标入组 60 人开始时间: 2021年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 60 adult patients aged between 18 - 65 years old, undergoing elective two or more levels of lumbar posterior spine fusion under general anesthesia will be enrolled in this study. Inclusion criteria include patients of both genders with American Society of Anesthesiologists (ASA) physical status I/II.

排除标准

  • Known hypersensitivity to lidocaine or ketamine, pregnancy, severe renal disorder, hepatic dysfunction, cardiac arrhythmias, severe cardiac or pulmonary disease, increased intraocular pressure, history of psychiatric disorders, epilepsy, history of alcohol or drug abuse, patients receiving beta-blockers or antiarrhythmics, uncontrolled diabetes or hypertension, and patients unable to operate patient-controlled analgesia (PCA) pump.

研究者

发起方
Mostafa Mansour Hussein

相似试验